Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches-Reference-Cited by-同舟云学术

Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches

Published:2020-02 Issue: Volume:263 Page:15-24
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Petralia Maria Cristina,Mazzon Emanuela,Fagone Paolo,Basile Maria Sofia,Lenzo Vittorio,Quattropani Maria Catena,Bendtzen Klaus,Nicoletti Ferdinando

Funder

MIF

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference98 articles.

1. Macrophage migration inhibitory factor and glucocorticoid sensitivity;Aeberli;Rheumatology,2006

2. Effect of voluntary running on expression of myokines in brains of rats with depression;Algaidi;Int. J. Immunopathol. Pharmacol.,2019

3. Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis;Anacker;Neuropsychopharmacology,2013

4. MIF expression in the rat brain: implications for neuronal function;Bacher;Mol. Med.,1998

5. Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice;Bay-Richter;J. Neuroinflamm.,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depression exacerbates myocardial ischemia-reperfusion injury in mice via CNR2 gene and MIF-AMPK signaling pathway;International Journal of Cardiology;2024-12

2. An intricate relationship between circadian rhythm dysfunction and psychiatric diseases;Exploration of Neuroscience;2024-08-23

3. Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine;Frontiers in Psychiatry;2023-11-09

4. Deiodinase Types 1 and 3 and Proinflammatory Cytokine Values May Discriminate Depressive Disorder Patients from Healthy Controls;Journal of Clinical Medicine;2023-09-24

5. Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancer;Tumor Biology;2023-08-02